Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cardiology
Researchers' work adds to cardiology body of knowledge
June 17th, 2005
Cardiology data are the focus of recent research from Taiwan, Canada and Belgium. Study 1: Inhibition of NF-kappa B activation can attenuate ischemia/reperfusion-induced contractility impairment via decreasing cardiomyocytic proinflammatory gene upregulation and matrix metalloproteinase expression. According to recent research published in the Journal of Cardiovascular Pharmacology, "Following cardiopulmonary bypass (CPB) and cardiac global ischemia and reperfusion, proinflammatory genes are upregulated, and nuclear factor (NF)-kappaB is involved in this regulation. We studied whether inactivation of NF-kappa B could decrease myocardial...
Source: Drug Week (2005-06-17)
|
